« Early Critic of Diabetes Drug Says Don’t Panic
Diabetes Associated with Faster Loss of Muscle Strength in the Elder »

FDA Approves Seven-day Glucose Monitor

WASHINGTON, Jun 4, 2007 (UPI via COMTEX) — The U.S. Food and Drug
Administration Monday approved a device that measures glucose levels
continuously for up to seven days in people with diabetes.

While a standard fingerstick test records a person’s glucose level as a
snapshot in time, the STS-7 Continuous Glucose Monitoring System measures
glucose levels every five minutes throughout a seven-day period. The FDA
said that additional information can be used to track patterns in glucose
levels throughout the week that wouldn’t be captured by fingerstick
measurements.

However, diabetics must still rely on the fingerstick test to decide whether
additional insulin is needed, the FDA added.

The STS-7 System, manufactured by DexCom Inc. of San Diego uses a disposable

sensor placed just below the skin in the abdomen to measure the level of
glucose in the fluid found in the body’s tissues. Sensor placement causes
minimal discomfort and can easily be done by patients themselves. An alarm
can be programmed to sound if a patient’s glucose level reaches pre-set lows
or pre-set highs.

A three-day version of the device was approved in March 2006.

This entry was posted on Tuesday, March 27th, 2007 at 9:48 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

One Response to “FDA Approves Seven-day Glucose Monitor”

  1. Neva Marjory Says:
    March 29th, 2007 at 7:54 pm

    i wonder what the cost will be?………….baz

    WASHINGTON, Jun 4, 2007 (UPI via COMTEX) — The U.S. Food and Drug
    Administration Monday approved a device that measures glucose levels
    continuously for up to seven days in people with diabetes.

    While a standard fingerstick test records a person’s glucose level as a
    snapshot in time, the STS-7 Continuous Glucose Monitoring System measures
    glucose levels every five minutes throughout a seven-day period. The FDA
    said that additional information can be used to track patterns in glucose
    levels throughout the week that wouldn’t be captured by fingerstick
    measurements.

    However, diabetics must still rely on the fingerstick test to decide whether
    additional insulin is needed, the FDA added.

    The STS-7 System, manufactured by DexCom Inc. of San Diego uses a disposable
    sensor placed just below the skin in the abdomen to measure the level of
    glucose in the fluid found in the body’s tissues. Sensor placement causes
    minimal discomfort and can easily be done by patients themselves. An alarm
    can be programmed to sound if a patient’s glucose level reaches pre-set lows
    or pre-set highs.

    A three-day version of the device was approved in March 2006.

    [Non-text portions of this message have been removed]

    [Non-text portions of this message have been removed]

Leave a Reply

You must be logged in to post a comment.